In this podcast, Dr. Richard L. Schilsky describes ASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR) Study and what has been learned since it launched in 2016.
Targeted Therapy for Claudin-18.2 and Combined PD-1 and TIGIT Immunotherapy for Advanced Cancers of the Stomach and Esophagus: The ASCO Plenary Series
Read about 2 studies from the November 2023 ASCO Plenary Series, which explore emerging treatments for advanced cancers of the stomach and esophagus.
Saving Time for Patients and Improving Well-Being Through Mindfulness and Fitness: Research from the 2023 ASCO Quality Care Symposium
Research from the 2023 ASCO Quality Care Symposium will highlight studies using text messaging to reduce time spent at the clinic, virtual mind-body fitness to reduce health care visits for people with cancer, and yoga to help reduce side effects of radiation therapy for people with head and neck cancer.
In this podcast, 3 members of the Cancer.Net Editorial Board discuss new research presented at the 2023 ASCO Annual Meeting in non-small cell lung cancer, small cell lung cancer, and mesothelioma.
2023 ASCO Annual Meeting Research Round Up: Progress in Preventing Melanoma Recurrence and Improving Equity in Cancer Care
In this podcast, 2 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting about preventing melanoma recurrence and reducing cancer disparities.
2023 ASCO Annual Meeting Research Round Up: Advances in Treating Gynecologic Cancers, Multiple Myeloma, and Head and Neck Cancer
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in ovarian cancer, uterine cancer, cervical cancer, multiple myeloma, and head and neck cancer.
Using Technology to Find Cancers Early and Exercise Improves Sexual Health for People With Prostate Cancer: Research from the 2023 ASCO Breakthrough Meeting
Read about four studies presented at the 2023 ASCO Breakthrough meeting, covering new ways to use technology to improve cancer screening, as well as a study that showed exercise can help improve sexual health for people with prostate cancer.
2023 ASCO Annual Meeting Research Round Up: Progress in Treating Breast Cancer, Lymphoma, Multiple Myeloma, and Brain Tumors
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in breast cancer, lymphoma, multiple myeloma, brain tumors, and von Hippel-Lindau syndrome.
Maintenance Therapy Delays Cancer Growth for People With Advanced or Recurrent Uterine Cancer: The ASCO Plenary Series
Read research from the July 2023 session of the ASCO Plenary Series, which highlights a study evaluating a potential maintenance therapy option for people with advanced or recurrent TP53 wild-type endometrial cancer.
ASCO Annual Meeting 2023: Radiation Therapy May Not Be Needed After Chemoimmunotherapy for Primary Mediastinal B-cell Lymphoma
The ASCO Annual Meeting is being held June 2 to 6. A study presented today shows that removing radiation therapy from the treatment plan for an aggressive form of lymphoma does not impact the risk of recurrence or overall survival.